NVTIA GABA-Lysine Calcium Composite Microsphere System for Promoting Calcium Absorption: Formulation Architecture, Gastrointestinal Dispersion, and Bone-Support Evidence

Abstract

We present an NVTIA composite microsphere system that combines a phosphorylated algal-calcium core, a GABA-L-lysine inclusion complex, a natto-derived MK-7 and Agaricus bisporus-derived vitamin D2 deposition module, and vitamin E protection. We analyzed the formulation-specific comparative dataset together with published human and translational evidence relevant to calcium absorption and skeletal utilization. In the comparative preparation, the integrated microsphere system dispersed completely in simulated intestinal fluid within 2 min, whereas the conventional comparator remained incompletely dispersed beyond 8 min. Core active retention reached at least 99.0% for GABA/L-lysine and at least 98.8% for MK-7/vitamin D2, and 30-day room-temperature retention remained at least 97.5%, compared with 82.3%, 86.7%, and 78.5%, respectively, in the comparator. Published studies aligned with the formulation modules: L-lysine significantly increased intestinal calcium absorption in 45 osteoporotic patients [2]; CPP enhanced skeletal 45Ca incorporation in growing rats [4]; algal calcium achieved a fractional absorption of 23.1 +/- 6.4% versus 14.7 +/- 6.4% for CaCO3 in postmenopausal women [5]; UV-B-irradiated button-mushroom vitamin D2 raised serum vitamin D indices similarly to supplemental vitamin D2 [7]; and recent meta-analytic evidence indicates that vitamin K, especially K2, primarily improves osteocalcin carboxylation and may help preserve lumbar-spine bone density [9]. We interpret these converging data as support for a coordinated calcium-delivery architecture that merits further bioavailability and outcome-based validation.